Nootropic merchant accounts UK
Nootropics straddle two acquirer worlds. Licensed supplement formulations can sometimes be placed with supplement-friendly acquirers, but research-compound nootropics and any cognitive claims push the whole account into high-risk territory, and mainstream processors often decline on category to avoid the ambiguity. Specialist nutraceutical and research-chemical acquirers underwrite nootropics depending on the exact product mix, at elevated rates with a rolling reserve. How you split licensed supplements from research compounds determines the route.
Legal status (UK)
Licensed nootropic supplements are legal under UK food-supplement and Novel Food rules. Research-only nootropic compounds (such as racetams) are a separate research-chemical category and must be labelled not for human consumption. Cognitive and health claims are tightly restricted under the GB Nutrition and Health Claims Register.
Best way to take Nootropic payments (UK)
Our pick
MerchantHQ, specialist Nootropic broker and account team
Mainstream UK acquirers (SumUp, Square, Zettle, Dojo, Worldpay, Barclaycard) decline Nootropic at onboarding or terminate after launch. We hold a specialist panel of UK high-risk acquirers that underwrite it. As a broker we match you to the right one for your licence, volume and processing history, then stay on as your named UK account team for the life of the agreement.
The acquirer pays our commission on signup, so it costs you nothing on top, and we never sell your details on. We disclose the risk classification upfront so the right underwriter is approached from the start.
Get matched to a Nootropic acquirerHigh-risk merchants are the most exposed to chargebacks, frozen funds and MATCH/TMF listings, and that is exactly what your MerchantHQ account team handles, for the life of the agreement.
How Nootropic placements work
Nootropic routes to specialist regulated-vertical acquirers matched per application rather than a published list. The right underwriter depends on your licence, volume and sub-category, so we approach it individually. We hold the relationships and disclose your risk classification upfront so the right acquirer is contacted from the start.
Typical pricing
- Rate
- 2.8% to 4.5% blended
- Settlement reserve
- 5% to 12% rolling reserve common
Indicative ranges based on typical UK high-risk acquirer pricing for this category. Your actual rate and reserve are set per merchant at underwriting and will differ.
Watch outs
- Keep licensed supplements and research-only compounds on clearly separated product lines; mixing them complicates underwriting.
- Cognitive, memory and focus claims must comply with the GB Nutrition and Health Claims Register or be removed.
- Research-compound nootropics must carry not-for-human-consumption labelling.
- Subscription billing raises chargeback risk and reserve levels.
Related
See the full high-risk merchant guide, how merchant accounts work, compare card terminals, or check card machine costs.
Founder & Managing Director, Muswell Rose, founder and PSC of Best Business Loans Ltd
Adam is the founder and managing director of Muswell Rose and a founder of Best Business Loans Ltd, the company behind MerchantHQ. His career runs through insurance, mortgages, commercial finance and fintech lending, including payments and merchant services. He writes the MerchantHQ library.
Last reviewed: 3 June 2026